Place of liver transplantation in the treatment of hepatocellular carcinoma in the normal liver

Liver Transplantation

Volumn 17, Issue SUPPL. 2, 2011, Pages

  Lerut, Jan ^a   Mergental, Hynek ^b   Kahn, Delawir ^c   Albuquerque, Luiz ^d   Marrero, Juan ^e   Vauthey, Jean Nicolas ^f   Porte, Robert J ^g  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; INTERFERON; RAPAMYCIN;

ADJUVANT THERAPY; ALGORITHM; ARTICLE; DISEASE FREE SURVIVAL; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER SURGERY; LIVER TRANSPLANTATION; LYMPHADENECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; EVIDENCE-BASED MEDICINE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053255578     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22393     Document Type: Article

References (52)

1. Cherqui D, Boudjema K, Celebic A, Laurent A, Roudot-Thoraval F,. Résection hépatique pour carcinome hépatocellulaire sur foie sain et pathologique en France. Résultats de l'enquête AFC sur la période 1990-2005. In:, Boudjema K, Cherqui D, eds. Cancer Hépatocellulaire. Rueil-Malmaison, France: Wolters Kluwer; 2006: 183-218.
2. Rahbari NN, Mehrabi A, Mollberg NM, Müller SA, Koch M, Büchler MW, Weitz J,. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 2011; 253: 453-469.
3. Trevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M,. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis 2010; 42: 341-347.
4. Lencioni R, Crocetti L, De Simone P, Filipponi F,. Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects. Transpl Int 2010; 23: 698-703.
5. Hwang S, Moon DB, Lee SG,. Liver transplantation and conventional surgery for advanced hepatocellular carcinoma. Transpl Int 2010; 23: 723-727.
6. Bhoori S, Sposito C, Germini A, Coppa J, Mazzaferro V,. The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis. Transpl Int 2010; 23: 712-722.
7. Sasaki Y, Imaoka S, Masutani S, Ohashi I, Ishikawa O, Koyama H, Iwanaga T,. Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery 1992; 112: 515-521.
8. Bismuth H, Chiche L, Castaing D,. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg 1995; 19: 35-41.
9. Smalley SR, Moertel CG, Hilton JF, Weiland LH, Weiand HS, Adson MA, et al. Hepatoma in the noncirrhotic liver. Cancer 1988; 62: 1414-1424.
10. Fong Y, Sun RL, Jarnagin W, Blumgart LH,. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790-799.
11. Poon RT, Fan ST, Lo CM, Liu CL, Ng IO, Wong J,. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 2000; 18: 1094-1101. (Pubitemid 30123788)
12. Shimada M, Rikimaru T, Sugimachi K, Hamatsu T, Yamashita Y, Aishima S, et al. The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver. J Am Coll Surg 2000; 191: 531-537.
13. Nagasue N, Ono T, Yamanoi A, Kohno H, El-Assal ON, Taniura H, Uchida M,. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg 2001; 88: 515-522. (Pubitemid 32291231)
14. Bilimoria MM, Lauwers GY, Doherty DA, Nagorney DM, Belghiti J, Do KA, et al.; for International Cooperative Study Group on Hepatocellular Carcinoma. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 2001; 136: 528-535. (Pubitemid 32417542)
15. Belghiti J, Regimbeau JM, Durand F, Kianmanesh AR, Dondero F, Terris B, et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology 2002; 49: 41-46. (Pubitemid 34289484)
16. Chen MF, Tsai HP, Jeng LB, Lee WC, Yeh CN, Yu MC, Hung CM,. Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg 2003; 27: 443-447.
17. Grazi GL, Cescon M, Ravaioli M, Ercolani G, Gardini A, Del Gaudio M, et al. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther 2003; 17 (suppl 2): 119-129. (Pubitemid 36831469)
18. Verhoef C, de Man RA, Zondervan PE, Eijkemans MJ, Tilanus HW, Ijzermans JN,. Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver. Dig Surg 2004; 21: 380-386. (Pubitemid 40458693)
19. Chang CH, Chau GY, Lui WY, Tsay SH, King KL, Wu CW,. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg 2004; 139: 320-325.
20. Lang H, Sotiropoulos GC, Dömland M, Frühauf NR, Paul A, Hüsing J, et al. Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis. Br J Surg 2005; 92: 198-202. (Pubitemid 40269334)
21. Dupont-Bierre E, Compagnon P, Raoul JL, Fayet G, de Lajarte-Thirouard AS, Boudjema K,. Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. J Am Coll Surg 2005; 201: 663-670. (Pubitemid 41539757)
22. Laurent C, Blanc JF, Nobili S, Sa Cunha A, le Bail B, Bioulac-Sage P, et al. Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg 2005; 201: 656-662. (Pubitemid 41539756)
23. Capussotti L, Muratore A, Amisano M, Massucco P, Polastri R, Bouzari H,. Liver resection for large-size hepatocellular carcinomas in 47 non-cirrhotic patientsâno mortality and long-term survival. Hepatogastroenterology 2006; 53: 768-772. (Pubitemid 44682999)
24. Eguchi S, Ijtsma AJ, Slooff MJ, Porte RJ, de Jong KP, Peeters PM, et al. Outcome and pattern of recurrence after curative resection for hepatocellular carcinoma in patients with a normal liver compared to patients with a diseased liver. Hepatogastroenterology 2006; 53: 592-596. (Pubitemid 44386966)
25. Taura K, Ikai I, Hatano E, Yasuchika K, Nakajima A, Tada M, et al. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients. Surgery 2007; 142: 685-694. (Pubitemid 350018839)
26. Hubert C, Sempoux C, Rahier J, Horsmans Y, Geubel A, Van Beers BE, et al. Prognostic risk factors of survival after resection of hepatocellular carcinoma. Hepatogastroenterology 2007; 54: 1791-1797. (Pubitemid 350068480)
27. Bage T, Le Treut YP, Hardwigsen J, Ananian P, Richa H, Campan P, Garcia S,. Prognostic factors after resection for hepatocellular carcinoma in nonfibrotic or moderately fibrotic liver. A 116-case European series. J Gastrointest Surg 2007; 11: 619-625.
28. Lubrano J, Huet E, Tsilividis B, Franaois A, Goria O, Riachi G, Scotté M,. Long-term outcome of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral hepatitis or alcohol abuse. World J Surg 2008; 32: 104-109. (Pubitemid 50003884)
29. Rayya F, Harms J, Bartels M, Uhlmann D, Hauss J, Fangmann J,. Results of resection and transplantation for hepatocellular carcinoma in cirrhosis and noncirrhosis. Transplant Proc 2008; 40: 933-935. (Pubitemid 351794300)
30. Xu L, Huang L, Li BK, Zhang YQ, Li JQ, Yuan YF,. Clinicopathologic features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver. Dig Surg 2008; 25: 376-382.
31. Sotiropoulos GC, Bockhorn M, Sgourakis G, Brokalaki EI, Molmenti EP, Neuhäuser M, et al. R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis. Dig Dis Sci 2009; 54: 887-894.
32. Smoot RL, Nagorney DM, Chandan VS, Que FG, Schleck CD, Harmsen WS, Kendrick ML,. Resection of hepatocellular carcinoma in patients without cirrhosis. Br J Surg 2011; 98: 697-703.
33. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107: 521-527. (Pubitemid 20156653)
34. Torzilli G, Montorsi M, Del Fabbro D, Palmisano A, Donadon M, Makuuchi M,. Ultrasonographically guided surgical approach to liver tumours involving the hepatic veins close to the caval confluence. Br J Surg 2006; 93: 1238-1246. (Pubitemid 44547023)
35. Kokudo N, Makuuchi M,. Current role of portal vein embolization/hepatic artery chemoembolization. Surg Clin North Am 2004; 84: 643-657. (Pubitemid 38388288)
36. Kishi Y, Abdalla EK, Chun YS, Zorzi D, Madoff DC, Wallace MJ, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg 2009; 250: 540-548.
37. Houben KW, McCall JL,. Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review. Liver Transpl Surg 1999; 5: 91-95. (Pubitemid 29118209)
38. Mergental H, Porte RJ,. Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis. Transpl Int 2010; 23: 662-667.
39. Mergental H, Adam R, Kalicinski P, Ericzon BG, Friman S, Köningsrainer A, et al. Liver transplantation for hepatocellular carcinoma in non-cirrhotic livers [abstract]. Liver Transpl 2007; 13 (suppl 1): S119.
40. Pichlmayr R, Weimann A, Oldhafer KJ, Schlitt HJ, Klempnauer J, Bornscheuer A, et al. Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg 1995; 19: 807-813.
41. Figueras J, Ramos E, Ibañez L, Rafecas A, Fabregat J, Torras J, et al. Surgical treatment of hepatocellular carcinoma in cirrhotic and noncirrhotic patients. Transplant Proc 1999; 31: 2455-2456.
42. Schlitt HJ, Neipp M, Weimann A, Oldhafer KJ, Schmoll E, Boeker K, et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 1999; 17: 324-331.
43. Pinna AD, Iwatsuki S, Lee RG, Todo S, Madariaga JR, Marsh JW, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997; 26: 877-883. (Pubitemid 27413652)
44. El-Gazzaz G, Wong W, El-Hadary MK, Gunson BK, Mirza DF, Mayer AD, et al. Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma. Transpl Int 2000; 13 (suppl 1): S406-S409.
45. El-Serag HB, Davila JA,. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 2004; 39: 798-803. (Pubitemid 38337660)
46. Kakar S, Burgart LJ, Batts KP, Garcia J, Jain D, Ferrell LD,. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol 2005; 18: 1417-1423. (Pubitemid 41509395)
47. Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 2003; 97: 2006-2012. (Pubitemid 36397279)
48. Stipa F, Yoon SS, Liau KH, Fong Y, Jarnagin WR, D'Angelica M, et al. Outcome of patients with fibrolamellar hepatocellular carcinoma. Cancer 2006; 106: 1331-1338. (Pubitemid 43363911)
49. Patt YZ, Hassan MM, Lozano RD, Brown TD, Vauthey JN, Curley SA, Ellis LM,. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon alfa-2b for treatment of hepatocellular carcinoma. J Clin Oncol 2003; 21: 421-427. (Pubitemid 46606469)
50. Maniaci V, Davidson BR, Rolles K, Dhillon AP, Hackshaw A, Begent RH, Meyer T,. Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy. Eur J Surg Oncol 2009; 35: 617-621.
51. Vivarelli M, Dazzi A, Zanello M, Cucchetti A, Cescon M, Ravaioli M, et al. Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. Transplantation 2010; 89: 227-231.
52. Schnitzbauer AA, Zuelke C, Graeb C, Rochon J, Bilbao I, Burra P, et al. A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer 2010; 10: 190.